ADMINISTRATIVE SUPPLEMENTS FOR THE STUDY OF DRUG ABUSE AND HIV/AIDS Release Date: December 13, 1999 NOTICE: DA-00-003 National Institute on Drug Abuse PURPOSE The National Institute on Drug Abuse (NIDA) announces the availability of funds to administratively supplement existing federal research project grants for the study of issues related to drug abuse and HIV/AIDS. In an effort to improve and expand its research on drug abuse-related aspects of HIV/AIDS, NIDA will consider requests from current NIDA/NIH grantees and those supported by other federal agencies (e.g., the National Science Foundation (NSF), the Health Resources and Services Administration (HRSA), the Department of Defense (DOD), the National Institute of Justice (NIJ), the Department of Education (ED), to expand and/or enhance ongoing research to include drug use related HIV/AIDS issues. The primary intent of this program is to encourage grantees who have not focused on drug use-related HIV/AIDS issues to do so, thus recognizing that drug abuse and HIV/AIDS are two diseases that often co-occur and interact and that must be prevented and treated together and in parallel. Projects that currently focus solely on either AIDS-related or drug abuse issues are encouraged to strengthen efforts in the complementary area. Thus, grantees are encouraged to examine for HIV/AIDS relevance ongoing drug abuse research projects which may not have been designed to examine AIDS-related issues. Similarly, those doing AIDS research, but who have not investigated how drugs of abuse may act within their area of investigation, are encouraged to think about these issues and consider submitting an application. Examples of areas of programmatic interest to NIDA are available at the following website: http://www.nida.nih.gov/funding.html. These examples are not meant to be all- inclusive. Inquiries are encouraged regarding these examples and other areas that are not addressed. SPECIAL REQUIREMENTS Budget/Administrative Issues For FY 2000, approximately $1,000,000 will be available for funding of administrative research supplements to existing federal grant projects. Subject to availability of funds, similar amounts will be made available in future years. Administrative supplements are provide to cover unanticipated cost increases that are associated with achieving the objectives within the original scope of a project, and include cost increases that result from making modifications in a project in order to take advantage of opportunities that would increase the value of the project consistent with its originally recommended objectives and purposes. Administrative supplemental funding to NIDA grants is generally limited to 25 percent of the Council-recommended direct costs of the project or $100,000, whichever is less. This limitation does not apply to grants from other NIH Institutes or organizations, although these other grant authorities may impose their own restrictions. These applications undergo program, grants management, and budget review within NIDA. Sometimes an application for an administrative supplement is considered to be more appropriate for a competitive supplement. If this is judged to be the case, the Principal Investigator and applicant institution will be notified as soon as possible. An original and two copies of the application must be received in the Grants Management Branch (see address below) by August 1, 2000, in order to be considered eligible for these funds. Supplements may not exceed the stated life of the parent project. Parent grants that would require or be in the status of no-additional-cost extension during the supplement period will not be eligible for supplementation. Administrative supplements may not alter the scope of the parent grant. Applicants from outside NIDA must inform their Program Officer at their granting federal agency with respect to their intention to submit an application for these supplements and must submit with the application a letter from the granting agency stating that (1) the proposed supplement is judged to fit within the scope of the funded grant, and (2) the granting agency is willing to accept the supplement if funding by NIDA is offered. The letter must include the name and contact information for the Project Officer at the granting agency. A copy of the letter must be sent to the NIDA Center on AIDS and Other Medical Consequences of Drug Abuse at the address listed below. Also, for applicants for supplements to non-NIDA grants, a copy of the funded application for the parent grant and the summary statement must be included with the supplement application. Applicants for supplements to NIDA parent grants are requested to inform their Program Officer with respect to their intention to submit an application for these supplements and to submit with the application a letter identifying their NIDA Program Officer and stating that per contact with him/her the proposed supplement is judged to fit within the scope of the funded grant. Those applications that fit within the scope of the parent grant are evaluated by NIDA staff using the criteria listed below. Every supplement application submitted will be assigned to a NIDA Program Officer, who will then be the primary contact with NIDA for the applicant regarding programmatic issues and the status of the application. In the case of those with NIDA parent grants, the Program Officer will most likely be the same as on the parent grant. In the case of those with non-NIDA parent grants, the NIDA Program Officer will be assigned on the basis of the content of the application and will be asked to establish contact with the applicant. REVIEW CONSIDERATION Applications will be evaluated by NIDA staff. Review criteria include: - Potential significance of the proposed work to the area of drug abuse related aspects of HIV/AIDS; - Feasibility of the research plan; and - Consistency of the proposed work with the originally approved objectives. INQUIRIES Inquiries concerning this notice are encouraged. The opportunity to clarify issues or questions from potential applicants is welcome. Direct inquiries regarding programmatic issues to: Sander Genser, M.D., M.P.H. Center on AIDS and Other Medical Consequences of Drug Abuse National Institute on Drug Abuse 6001 Executive Boulevard, Rm.5198, MSC 9593 Bethesda, MD 20892-9593 Telephone : 301-443-1801 FAX : 301 443-4100 E-mail: sg73f@nih.gov Direct inquiries regarding fiscal matters to: Gary Fleming, J.D., M.A. Grants Management Branch National Institute on Drug Abuse 6001 Executive Blvd., Room 3131, MSC 9541 Bethesda, MD 20892-9541 Telephone: (301) 443-6710 FAX : (301) 594-6847 E-mail: gf6s@nih.gov APPLICATION PROCEDURES Supplement applications are to be submitted on the grant application form PHS 398 (rev. 4/98). Application kits are available at most institutional offices of sponsored research and may be obtained from the Division of Extramural Outreach and Information Resources, National Institutes of Health, 6701 Rockledge Drive, MSC 7910, Bethesda, MD 20892-7910, telephone: (301) 710-0267, E-mail: GrantsInfo@nih.gov. Submit a signed typewritten original of the application, including the Checklist, and two signed photocopies to: CHIEF, GRANTS MANAGEMENT BRANCH NATIONAL INSTITUTE ON DRUG ABUSE 6001 EXECUTIVE BOULEVARD, ROOM 3131, MSC 9541 BETHESDA, MD 20892-9541 ROCKVILLE, MD 20852 (for express/courier services) To be eligible for consideration for these FY 2000 funds, administrative supplement applications must be received by August 1, 2000. Applications for administrative supplements may be submitted any time during FY 200 before the August 1, 2000 deadline. Such applications will receive a review with one of the following four possible outcomes: (1) recommendation for funding, (2) recommendation for not being funded, (3) suggestion for resubmission as a competitive supplement application, or (4) deferral for later consideration with remaining administrative supplements. If an administrative supplement application for these funds is received after August 1, 2000, it will be returned to the applicant without review.
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |